InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,712.69
(
-0.28%
)
US TECH 100
19,512.00
(
0.37%
)
Dow Jones
41,794.60
(
-0.61%
)
Brent Oil
75.43
(
0.41%
)
Bitcoin
68,834.69
(
1.50%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gdollasign

Send PM Follow Ignore
Followers 6
Posts 973
Boards Moderated 0
Alias Born 06/08/2010

gdollasign

Re: trading_cyclist post# 49538

Monday, 05/26/2014 4:45:04 PM

Monday, May 26, 2014 4:45:04 PM

Post# of 80490
Here is one reason why Iclusig wont be a true presence in GIST...unfortunately.

From the 2014 ASCO abstract..

Enrollment of new pts is on hold due to safety observations in other ponatinib trials; enrollment criteria are being revised to include only pts with failure of all 3 TKIs approved for GIST. NCT01874665

To me it now becomes a waste of time and money to pursue GIST.

G$
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up